Browse > Article
http://dx.doi.org/10.5012/bkcs.2009.30.11.2739

Hologram and Receptor-Guided 3D QSAR Analysis of Anilinobipyridine JNK3 Inhibitors  

Chung, Jae-Yoon (Life Sciences Research Division, Korea Institute of Science and Technology,Life Sciences Research Division, Korea Institute of Science and Technology)
Cho, Art-E (Department of Biotechnology and Bioinformatics, Korea University)
Hah, Jung-Mi (Life Sciences Research Division, Korea Institute of Science and Technology)
Publication Information
Abstract
Hologram and three dimensional quantitative structure activity relationship (3D QSAR) studies for a series of anilinobipyridine JNK3 inhibitors were performed using various alignment-based comparative molecular field analysis (COMFA) and comparative molecular similarity indices analysis (CoMSIA). The in vitro JNK3 inhibitory activity exhibited a strong correlation with steric and electrostatic factors of the molecules. Using four different types of alignments, the best model was selected based on the statistical significance of CoMFA ($q_2\;=\;0.728,\;r_2\;=\;0.865$), CoMSIA ($q_2\;=\;0.706,\;r_2\;=\;0.960$) and Hologram QSAR (HQSAR: $q_2\;=\;0.838,\;r_2\;=\;0.935$). The graphical analysis of produced CoMFA and CoMSIA contour maps in the active site indicated that steric and electrostatic interactions with key residues are crucial for potency and selectivity of JNK3 inhibitors. The HQSAR analysis showed a similar qualitative conclusion. We believe these findings could be utilized for further development of more potent and selective JNK3 inhibitors.
Keywords
JNK3; QSAR; CoMFA; CoMSIA; HQSAR;
Citations & Related Records

Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Davis, R. J. Cell 2000, 103, 239   DOI   ScienceOn
2 Manning, A.; Davis, R. Nature Reviews Drug Discovery 2003, 2, 554   DOI   ScienceOn
3 Gupta, S.; Barrett, T.; Whitmarsh, A.; Cavanagh, J.; Sluss, H.; Derijard, B.; Davis, R. The EMBO Journal 1996, 15, 2760
4 Martin, J.; Mohit, A.; Miller, C. Molecular Brain Research 1996, 35, 47   DOI   ScienceOn
5 Kuan, C.; Yang, D.; Roy, D.; Davis, R.; Rakic, P.; Flavell, R. NEURON-CAMBRIDGE MA- 1999, 22, 667   DOI   ScienceOn
6 Shemetulskis, N.; Weininger, D.; Blankley, C.; Yang, J.; Humblet, C. J. Chem. Inf. Comput. Sci. 1996, 36, 862   DOI   ScienceOn
7 Lowis, D. R. Tripos Technical Notes 1997, 1
8 Maestro version 8.5, S., LLC, New York, NY 2008
9 LigPrep version 2.2, S., LLC, New York, NY 2005
10 Wold, S.; Sjostrom, M.; Eriksson, L. Chemometrics and Intelligent Laboratory Systems 2001, 58, 109   DOI   ScienceOn
11 Kettaneh, N.; Berglund, A.; Wold, S. Computational Statistics and Data Analysis 2005, 48, 69   DOI   ScienceOn
12 Jaguar version 7.5, S., LLC, New York, NY 2008
13 Phase version 3.0, S., LLC, New York, NY 2008
14 Scapin, G.; Patel, S.; Lisnock, J.; Becker, J.; LoGrasso, P. Chemistry & Biology 2003, 10, 705   DOI   ScienceOn
15 Viklund, J.; Womack, P.; Xue, Y.; Oehberg, L. Bioorganic & Medicinal Chemistry Letters 2005, 15, 5095   DOI   ScienceOn
16 Noble, M. E. M.; Endicott, J. A.; Johnson, L. N. Science 2004, 303, 1800   DOI   ScienceOn
17 Nolen, B.; Taylor, S.; Ghosh, G. Molecular Cell 2004, 15, 661   DOI   ScienceOn
18 Cramer III, R.; Patterson, D.; Bunce, J. J. Am. Chem. Soc. 1988, 110, 5959   DOI   ScienceOn
19 Klebe, G.; Abraham, U. Journal of Computer-Aided Molecular Design 1999, 13, 1   DOI   ScienceOn
20 Klebe, G.; Abraham, U.; Mietzner, T. J. Med. Chem. 1994, 37, 4130   DOI   ScienceOn
21 ConfGen version 2.0, S., LLC, New York, NY 2008
22 Glide version 5.0, S., LLC, New York, NY 2008
23 MacroModel version 9.6, S., LLC, New York, NY 2008
24 SYBYL 7.3, T. I., 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA